{"id":1418,"date":"2025-06-10T07:58:45","date_gmt":"2025-06-10T07:58:45","guid":{"rendered":"https:\/\/intrigence.com\/?p=1418"},"modified":"2025-07-17T10:57:52","modified_gmt":"2025-07-17T10:57:52","slug":"intrinseque-health-malaysia-granted-md-status-to-advance-digital-clinical-supply-chain-innovation-through-intrigence","status":"publish","type":"post","link":"https:\/\/intrigence.com\/home\/intrinseque-health-malaysia-granted-md-status-to-advance-digital-clinical-supply-chain-innovation-through-intrigence\/","title":{"rendered":"Intrinseque Health (Malaysia) Granted MD Status to Advance Digital Clinical Supply Chain Innovation through INTRIGENCE"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Newsroom<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Intrinseque Health Wins Award For Best Clinical Supply Chain Solutions Provider 2025 \u2013 Singapore<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Date: 19-05-2025<\/p>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t
Intrinseque Health wins Best Clinical Supply Chain Solutions Provider 2025 \u2013 Singapore, recognized for excellence in global clinical supply chain management.<\/h6>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

MELAKA, MALAYSIA, June 9, 2025 \u2014 Intrinseque Health (Malaysia) Sdn. Bhd. has been granted Malaysia Digital (MD) Status by the Malaysia Digital Coordination Committee (MD-CC), under the Malaysia Digital Economy Corporation (MDEC). This recognition underscores the company\u2019s growing role in digitalizing the clinical supply chain sector and reinforces Malaysia\u2019s position as a strategic hub for innovation in life sciences. At the core of Intrinseque Health\u2019s digital strategy is INTRIGENCE \u2013 an AI-enabled platform built to simplify, integrate, and modernize the clinical supply chain lifecycle.<\/p>

Designed for sponsors, CROs, biotech firms, pharma companies, and service providers, INTRIGENCE delivers:
1. Integrated Supply Planning and Forecasting
2. Real-time Monitoring of Supply and Demand
3. Centralized Vendor Communication
4. Automated Compliance and Documentation
5. Data-driven Insights for Better Decision-making<\/p>

\u00a0<\/p>

\u201cWe are honored to be granted the Malaysia Digital (MD) Status by MDEC.This recognition is a strong endorsement of our commitment to advancing digital innovation in the clinical trial ecosystem. Our vision is to establish INTRIGENCE as the digital backbone of clinical supply chain- supporting faster, more resilient trials and driving long-term value for the global clinical research community.\u201d\u2013 Nitin Jain, President & CEO, Intrinseque Health<\/p>

INTRIGENCE is not just a digital tool, it\u2019s a strategic asset for clinical trials. Built to solve the persistent challenges of planning, visibility, compliance, and collaboration, the platform integrates every aspect of clinical supply chain management into a single intelligent system. It enables clinical development sponsors, contract research organizations (CROs), biotech companies, pharmaceutical companies, and clinical supply chain service providers to make faster, more informed decisions while reducing delays and ensuring that patients receive what they need, on time, without wastage and compromise.\u00a0<\/p>

As clinical trials grow more complex and decentralized, platform like INTRIGENCE is becoming essential to maintaining operational efficiency, patient safety, forecasting and regulatory compliance. With support from the Malaysia Digital (MD) Status, Intrinseque Health is committed to further enhancing the capabilities of INTRIGENCE, investing in local tech talent, and expanding its regional and global impact.<\/p>

\u00a0<\/p>

About Intrinseque Health<\/p>


Intrinseque Health is an EN ISO 13485, ISO 9001 and GDPMDS certified global clinical development support organisation, accomplished in facilitating the development of clinical trialstudies globally. Around the globe, Intrinseque Health has offices in countries like the United States (Delaware), The Netherlands (Amsterdam), United Kingdom (London), China (Beijing), Taiwan (Taipei) & Korea (Seoul), India (Delhi) and Singapore. Being managed by drug development professionals with over 300 years of combined experience supporting global clinical trials across various therapeutic areas, the team at Intrinseque Health knows and understands the needs of the clients while providing best-in-class solutions to overcome the hurdles and pain points of conducting a clinical trial.<\/p>

Intrinseque Health is the industry expert in solving clinical supply chain challenges, such as product availability & lead times, selection of in-country sourcing Vs. import, import regulations and IOR\/EOR requirements, storage & warehousing, kitting, labelling & printing, installation, calibration, validation, servicing & maintenance of equipment and supplies, local sourcing, and procurement services, all while maintaining the highest levels of quality throughout study timelines. Intrinseque Health engages early with its clients and utilises an operationalmethodology based on a proven, cost-effective clinical supply chain strategy for each clinical trial. It firmly believes that even the most minor and essential items, irrespective of their utility, should be there every time because nothing is more important than the value of patients\u2019 life. Intrinseque Health aims to become the global leader in clinical trial support services and constantly thrives in innovating and offering unique solutions.<\/p>

\u00a0<\/p>

Prajjwal Sharma
Intrinseque Health
+65 9101 9015<\/p>

contact@intrinsequehealth.com<\/p><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Newsroom Intrinseque Health Wins Award For Best Clinical Supply Chain Solutions Provider 2025 \u2013 Singapore Date: 19-05-2025 Intrinseque Health wins Best Clinical Supply Chain Solutions Provider 2025 \u2013 Singapore, recognized for excellence in global clinical supply chain management. MELAKA, MALAYSIA, June 9, 2025 \u2014 Intrinseque Health (Malaysia) Sdn. Bhd. has been granted Malaysia Digital (MD) Status by the Malaysia Digital Coordination Committee (MD-CC), under the Malaysia Digital Economy Corporation (MDEC). This recognition underscores the company\u2019s growing role in digitalizing the clinical supply chain sector and reinforces Malaysia\u2019s position as a strategic hub for innovation in life sciences. At the core of Intrinseque Health\u2019s digital strategy is INTRIGENCE \u2013 an AI-enabled platform built to simplify, integrate, and modernize the clinical supply chain lifecycle. Designed for sponsors, CROs, biotech firms, pharma companies, and service providers, INTRIGENCE delivers:1. Integrated Supply Planning and Forecasting2. Real-time Monitoring of Supply and Demand3. Centralized Vendor Communication4. Automated Compliance and Documentation5. Data-driven Insights for Better Decision-making \u00a0 \u201cWe are honored to be granted the Malaysia Digital (MD) Status by MDEC.This recognition is a strong endorsement of our commitment to advancing digital innovation in the clinical trial ecosystem. Our vision is to establish INTRIGENCE as the digital backbone of clinical supply chain- supporting faster, more resilient trials and driving long-term value for the global clinical research community.\u201d\u2013 Nitin Jain, President & CEO, Intrinseque Health INTRIGENCE is not just a digital tool, it\u2019s a strategic asset for clinical trials. Built to solve the persistent challenges of planning, visibility, compliance, and collaboration, the platform integrates every aspect of clinical supply chain management into a single intelligent system. It enables clinical development sponsors, contract research organizations (CROs), biotech companies, pharmaceutical companies, and clinical supply chain service providers to make faster, more informed decisions while reducing delays and ensuring that patients receive what they need, on time, without wastage and compromise.\u00a0 As clinical trials grow more complex and decentralized, platform like INTRIGENCE is becoming essential to maintaining operational efficiency, patient safety, forecasting and regulatory compliance. With support from the Malaysia Digital (MD) Status, Intrinseque Health is committed to further enhancing the capabilities of INTRIGENCE, investing in local tech talent, and expanding its regional and global impact. \u00a0 About Intrinseque Health Intrinseque Health is an EN ISO 13485, ISO 9001 and GDPMDS certified global clinical development support organisation, accomplished in facilitating the development of clinical trialstudies globally. Around the globe, Intrinseque Health has offices in countries like the United States (Delaware), The Netherlands (Amsterdam), United Kingdom (London), China (Beijing), Taiwan (Taipei) & Korea (Seoul), India (Delhi) and Singapore. Being managed by drug development professionals with over 300 years of combined experience supporting global clinical trials across various therapeutic areas, the team at Intrinseque Health knows and understands the needs of the clients while providing best-in-class solutions to overcome the hurdles and pain points of conducting a clinical trial. Intrinseque Health is the industry expert in solving clinical supply chain challenges, such as product availability & lead times, selection of in-country sourcing Vs. import, import regulations and IOR\/EOR requirements, storage & warehousing, kitting, labelling & printing, installation, calibration, validation, servicing & maintenance of equipment and supplies, local sourcing, and procurement services, all while maintaining the highest levels of quality throughout study timelines. Intrinseque Health engages early with its clients and utilises an operationalmethodology based on a proven, cost-effective clinical supply chain strategy for each clinical trial. It firmly believes that even the most minor and essential items, irrespective of their utility, should be there every time because nothing is more important than the value of patients\u2019 life. Intrinseque Health aims to become the global leader in clinical trial support services and constantly thrives in innovating and offering unique solutions. \u00a0 Prajjwal SharmaIntrinseque Health+65 9101 9015 contact@intrinsequehealth.com<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-1418","post","type-post","status-publish","format-standard","hentry","category-newsroom"],"yoast_head":"\nIntrinseque Health (Malaysia) Granted MD Status to Advance Digital Clinical Supply Chain Innovation through INTRIGENCE - intrigence.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/intrigence.com\/home\/intrinseque-health-malaysia-granted-md-status-to-advance-digital-clinical-supply-chain-innovation-through-intrigence\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Intrinseque Health (Malaysia) Granted MD Status to Advance Digital Clinical Supply Chain Innovation through INTRIGENCE - intrigence.com\" \/>\n<meta property=\"og:description\" content=\"Newsroom Intrinseque Health Wins Award For Best Clinical Supply Chain Solutions Provider 2025 \u2013 Singapore Date: 19-05-2025 Intrinseque Health wins Best Clinical Supply Chain Solutions Provider 2025 \u2013 Singapore, recognized for excellence in global clinical supply chain management. MELAKA, MALAYSIA, June 9, 2025 \u2014 Intrinseque Health (Malaysia) Sdn. Bhd. has been granted Malaysia Digital (MD) Status by the Malaysia Digital Coordination Committee (MD-CC), under the Malaysia Digital Economy Corporation (MDEC). This recognition underscores the company\u2019s growing role in digitalizing the clinical supply chain sector and reinforces Malaysia\u2019s position as a strategic hub for innovation in life sciences. At the core of Intrinseque Health\u2019s digital strategy is INTRIGENCE \u2013 an AI-enabled platform built to simplify, integrate, and modernize the clinical supply chain lifecycle. Designed for sponsors, CROs, biotech firms, pharma companies, and service providers, INTRIGENCE delivers:1. Integrated Supply Planning and Forecasting2. Real-time Monitoring of Supply and Demand3. Centralized Vendor Communication4. Automated Compliance and Documentation5. Data-driven Insights for Better Decision-making \u00a0 \u201cWe are honored to be granted the Malaysia Digital (MD) Status by MDEC.This recognition is a strong endorsement of our commitment to advancing digital innovation in the clinical trial ecosystem. Our vision is to establish INTRIGENCE as the digital backbone of clinical supply chain- supporting faster, more resilient trials and driving long-term value for the global clinical research community.\u201d\u2013 Nitin Jain, President & CEO, Intrinseque Health INTRIGENCE is not just a digital tool, it\u2019s a strategic asset for clinical trials. Built to solve the persistent challenges of planning, visibility, compliance, and collaboration, the platform integrates every aspect of clinical supply chain management into a single intelligent system. It enables clinical development sponsors, contract research organizations (CROs), biotech companies, pharmaceutical companies, and clinical supply chain service providers to make faster, more informed decisions while reducing delays and ensuring that patients receive what they need, on time, without wastage and compromise.\u00a0 As clinical trials grow more complex and decentralized, platform like INTRIGENCE is becoming essential to maintaining operational efficiency, patient safety, forecasting and regulatory compliance. With support from the Malaysia Digital (MD) Status, Intrinseque Health is committed to further enhancing the capabilities of INTRIGENCE, investing in local tech talent, and expanding its regional and global impact. \u00a0 About Intrinseque Health Intrinseque Health is an EN ISO 13485, ISO 9001 and GDPMDS certified global clinical development support organisation, accomplished in facilitating the development of clinical trialstudies globally. Around the globe, Intrinseque Health has offices in countries like the United States (Delaware), The Netherlands (Amsterdam), United Kingdom (London), China (Beijing), Taiwan (Taipei) & Korea (Seoul), India (Delhi) and Singapore. Being managed by drug development professionals with over 300 years of combined experience supporting global clinical trials across various therapeutic areas, the team at Intrinseque Health knows and understands the needs of the clients while providing best-in-class solutions to overcome the hurdles and pain points of conducting a clinical trial. Intrinseque Health is the industry expert in solving clinical supply chain challenges, such as product availability & lead times, selection of in-country sourcing Vs. import, import regulations and IOR\/EOR requirements, storage & warehousing, kitting, labelling & printing, installation, calibration, validation, servicing & maintenance of equipment and supplies, local sourcing, and procurement services, all while maintaining the highest levels of quality throughout study timelines. Intrinseque Health engages early with its clients and utilises an operationalmethodology based on a proven, cost-effective clinical supply chain strategy for each clinical trial. It firmly believes that even the most minor and essential items, irrespective of their utility, should be there every time because nothing is more important than the value of patients\u2019 life. Intrinseque Health aims to become the global leader in clinical trial support services and constantly thrives in innovating and offering unique solutions. \u00a0 Prajjwal SharmaIntrinseque Health+65 9101 9015 contact@intrinsequehealth.com\" \/>\n<meta property=\"og:url\" content=\"https:\/\/intrigence.com\/home\/intrinseque-health-malaysia-granted-md-status-to-advance-digital-clinical-supply-chain-innovation-through-intrigence\/\" \/>\n<meta property=\"og:site_name\" content=\"intrigence.com\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-10T07:58:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-17T10:57:52+00:00\" \/>\n<meta name=\"author\" content=\"wp-user-vx6ciq\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"wp-user-vx6ciq\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/intrigence.com\/home\/intrinseque-health-malaysia-granted-md-status-to-advance-digital-clinical-supply-chain-innovation-through-intrigence\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/intrigence.com\/home\/intrinseque-health-malaysia-granted-md-status-to-advance-digital-clinical-supply-chain-innovation-through-intrigence\/\"},\"author\":{\"name\":\"wp-user-vx6ciq\",\"@id\":\"https:\/\/intrigence.com\/home\/#\/schema\/person\/5922828aaf1205f90f184761b59ac52d\"},\"headline\":\"Intrinseque Health (Malaysia) Granted MD Status to Advance Digital Clinical Supply Chain Innovation through INTRIGENCE\",\"datePublished\":\"2025-06-10T07:58:45+00:00\",\"dateModified\":\"2025-07-17T10:57:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/intrigence.com\/home\/intrinseque-health-malaysia-granted-md-status-to-advance-digital-clinical-supply-chain-innovation-through-intrigence\/\"},\"wordCount\":629,\"publisher\":{\"@id\":\"https:\/\/intrigence.com\/home\/#organization\"},\"articleSection\":[\"Newsroom\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/intrigence.com\/home\/intrinseque-health-malaysia-granted-md-status-to-advance-digital-clinical-supply-chain-innovation-through-intrigence\/\",\"url\":\"https:\/\/intrigence.com\/home\/intrinseque-health-malaysia-granted-md-status-to-advance-digital-clinical-supply-chain-innovation-through-intrigence\/\",\"name\":\"Intrinseque Health (Malaysia) Granted MD Status to Advance Digital Clinical Supply Chain Innovation through INTRIGENCE - intrigence.com\",\"isPartOf\":{\"@id\":\"https:\/\/intrigence.com\/home\/#website\"},\"datePublished\":\"2025-06-10T07:58:45+00:00\",\"dateModified\":\"2025-07-17T10:57:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/intrigence.com\/home\/intrinseque-health-malaysia-granted-md-status-to-advance-digital-clinical-supply-chain-innovation-through-intrigence\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/intrigence.com\/home\/intrinseque-health-malaysia-granted-md-status-to-advance-digital-clinical-supply-chain-innovation-through-intrigence\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/intrigence.com\/home\/intrinseque-health-malaysia-granted-md-status-to-advance-digital-clinical-supply-chain-innovation-through-intrigence\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/intrigence.com\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Intrinseque Health (Malaysia) Granted MD Status to Advance Digital Clinical Supply Chain Innovation through INTRIGENCE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/intrigence.com\/home\/#website\",\"url\":\"https:\/\/intrigence.com\/home\/\",\"name\":\"intrigence.com\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/intrigence.com\/home\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/intrigence.com\/home\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/intrigence.com\/home\/#organization\",\"name\":\"intrigence.com\",\"url\":\"https:\/\/intrigence.com\/home\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/intrigence.com\/home\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/intrigence.com\/home\/wp-content\/uploads\/2025\/05\/cropped-Untitled-design-8.png\",\"contentUrl\":\"https:\/\/intrigence.com\/home\/wp-content\/uploads\/2025\/05\/cropped-Untitled-design-8.png\",\"width\":2271,\"height\":302,\"caption\":\"intrigence.com\"},\"image\":{\"@id\":\"https:\/\/intrigence.com\/home\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/intrigence.com\/home\/#\/schema\/person\/5922828aaf1205f90f184761b59ac52d\",\"name\":\"wp-user-vx6ciq\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/intrigence.com\/home\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f0add29126860514c28d228b52a705b8c831acd20a0fee2388d1f1d5c66cf8ce?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f0add29126860514c28d228b52a705b8c831acd20a0fee2388d1f1d5c66cf8ce?s=96&d=mm&r=g\",\"caption\":\"wp-user-vx6ciq\"},\"sameAs\":[\"https:\/\/intrigence.com\"],\"url\":\"https:\/\/intrigence.com\/home\/author\/wp-user-vx6ciq\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Intrinseque Health (Malaysia) Granted MD Status to Advance Digital Clinical Supply Chain Innovation through INTRIGENCE - intrigence.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/intrigence.com\/home\/intrinseque-health-malaysia-granted-md-status-to-advance-digital-clinical-supply-chain-innovation-through-intrigence\/","og_locale":"en_US","og_type":"article","og_title":"Intrinseque Health (Malaysia) Granted MD Status to Advance Digital Clinical Supply Chain Innovation through INTRIGENCE - intrigence.com","og_description":"Newsroom Intrinseque Health Wins Award For Best Clinical Supply Chain Solutions Provider 2025 \u2013 Singapore Date: 19-05-2025 Intrinseque Health wins Best Clinical Supply Chain Solutions Provider 2025 \u2013 Singapore, recognized for excellence in global clinical supply chain management. MELAKA, MALAYSIA, June 9, 2025 \u2014 Intrinseque Health (Malaysia) Sdn. Bhd. has been granted Malaysia Digital (MD) Status by the Malaysia Digital Coordination Committee (MD-CC), under the Malaysia Digital Economy Corporation (MDEC). This recognition underscores the company\u2019s growing role in digitalizing the clinical supply chain sector and reinforces Malaysia\u2019s position as a strategic hub for innovation in life sciences. At the core of Intrinseque Health\u2019s digital strategy is INTRIGENCE \u2013 an AI-enabled platform built to simplify, integrate, and modernize the clinical supply chain lifecycle. Designed for sponsors, CROs, biotech firms, pharma companies, and service providers, INTRIGENCE delivers:1. Integrated Supply Planning and Forecasting2. Real-time Monitoring of Supply and Demand3. Centralized Vendor Communication4. Automated Compliance and Documentation5. Data-driven Insights for Better Decision-making \u00a0 \u201cWe are honored to be granted the Malaysia Digital (MD) Status by MDEC.This recognition is a strong endorsement of our commitment to advancing digital innovation in the clinical trial ecosystem. Our vision is to establish INTRIGENCE as the digital backbone of clinical supply chain- supporting faster, more resilient trials and driving long-term value for the global clinical research community.\u201d\u2013 Nitin Jain, President & CEO, Intrinseque Health INTRIGENCE is not just a digital tool, it\u2019s a strategic asset for clinical trials. Built to solve the persistent challenges of planning, visibility, compliance, and collaboration, the platform integrates every aspect of clinical supply chain management into a single intelligent system. It enables clinical development sponsors, contract research organizations (CROs), biotech companies, pharmaceutical companies, and clinical supply chain service providers to make faster, more informed decisions while reducing delays and ensuring that patients receive what they need, on time, without wastage and compromise.\u00a0 As clinical trials grow more complex and decentralized, platform like INTRIGENCE is becoming essential to maintaining operational efficiency, patient safety, forecasting and regulatory compliance. With support from the Malaysia Digital (MD) Status, Intrinseque Health is committed to further enhancing the capabilities of INTRIGENCE, investing in local tech talent, and expanding its regional and global impact. \u00a0 About Intrinseque Health Intrinseque Health is an EN ISO 13485, ISO 9001 and GDPMDS certified global clinical development support organisation, accomplished in facilitating the development of clinical trialstudies globally. Around the globe, Intrinseque Health has offices in countries like the United States (Delaware), The Netherlands (Amsterdam), United Kingdom (London), China (Beijing), Taiwan (Taipei) & Korea (Seoul), India (Delhi) and Singapore. Being managed by drug development professionals with over 300 years of combined experience supporting global clinical trials across various therapeutic areas, the team at Intrinseque Health knows and understands the needs of the clients while providing best-in-class solutions to overcome the hurdles and pain points of conducting a clinical trial. Intrinseque Health is the industry expert in solving clinical supply chain challenges, such as product availability & lead times, selection of in-country sourcing Vs. import, import regulations and IOR\/EOR requirements, storage & warehousing, kitting, labelling & printing, installation, calibration, validation, servicing & maintenance of equipment and supplies, local sourcing, and procurement services, all while maintaining the highest levels of quality throughout study timelines. Intrinseque Health engages early with its clients and utilises an operationalmethodology based on a proven, cost-effective clinical supply chain strategy for each clinical trial. It firmly believes that even the most minor and essential items, irrespective of their utility, should be there every time because nothing is more important than the value of patients\u2019 life. Intrinseque Health aims to become the global leader in clinical trial support services and constantly thrives in innovating and offering unique solutions. \u00a0 Prajjwal SharmaIntrinseque Health+65 9101 9015 contact@intrinsequehealth.com","og_url":"https:\/\/intrigence.com\/home\/intrinseque-health-malaysia-granted-md-status-to-advance-digital-clinical-supply-chain-innovation-through-intrigence\/","og_site_name":"intrigence.com","article_published_time":"2025-06-10T07:58:45+00:00","article_modified_time":"2025-07-17T10:57:52+00:00","author":"wp-user-vx6ciq","twitter_card":"summary_large_image","twitter_misc":{"Written by":"wp-user-vx6ciq","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/intrigence.com\/home\/intrinseque-health-malaysia-granted-md-status-to-advance-digital-clinical-supply-chain-innovation-through-intrigence\/#article","isPartOf":{"@id":"https:\/\/intrigence.com\/home\/intrinseque-health-malaysia-granted-md-status-to-advance-digital-clinical-supply-chain-innovation-through-intrigence\/"},"author":{"name":"wp-user-vx6ciq","@id":"https:\/\/intrigence.com\/home\/#\/schema\/person\/5922828aaf1205f90f184761b59ac52d"},"headline":"Intrinseque Health (Malaysia) Granted MD Status to Advance Digital Clinical Supply Chain Innovation through INTRIGENCE","datePublished":"2025-06-10T07:58:45+00:00","dateModified":"2025-07-17T10:57:52+00:00","mainEntityOfPage":{"@id":"https:\/\/intrigence.com\/home\/intrinseque-health-malaysia-granted-md-status-to-advance-digital-clinical-supply-chain-innovation-through-intrigence\/"},"wordCount":629,"publisher":{"@id":"https:\/\/intrigence.com\/home\/#organization"},"articleSection":["Newsroom"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/intrigence.com\/home\/intrinseque-health-malaysia-granted-md-status-to-advance-digital-clinical-supply-chain-innovation-through-intrigence\/","url":"https:\/\/intrigence.com\/home\/intrinseque-health-malaysia-granted-md-status-to-advance-digital-clinical-supply-chain-innovation-through-intrigence\/","name":"Intrinseque Health (Malaysia) Granted MD Status to Advance Digital Clinical Supply Chain Innovation through INTRIGENCE - intrigence.com","isPartOf":{"@id":"https:\/\/intrigence.com\/home\/#website"},"datePublished":"2025-06-10T07:58:45+00:00","dateModified":"2025-07-17T10:57:52+00:00","breadcrumb":{"@id":"https:\/\/intrigence.com\/home\/intrinseque-health-malaysia-granted-md-status-to-advance-digital-clinical-supply-chain-innovation-through-intrigence\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/intrigence.com\/home\/intrinseque-health-malaysia-granted-md-status-to-advance-digital-clinical-supply-chain-innovation-through-intrigence\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/intrigence.com\/home\/intrinseque-health-malaysia-granted-md-status-to-advance-digital-clinical-supply-chain-innovation-through-intrigence\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/intrigence.com\/home\/"},{"@type":"ListItem","position":2,"name":"Intrinseque Health (Malaysia) Granted MD Status to Advance Digital Clinical Supply Chain Innovation through INTRIGENCE"}]},{"@type":"WebSite","@id":"https:\/\/intrigence.com\/home\/#website","url":"https:\/\/intrigence.com\/home\/","name":"intrigence.com","description":"","publisher":{"@id":"https:\/\/intrigence.com\/home\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/intrigence.com\/home\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/intrigence.com\/home\/#organization","name":"intrigence.com","url":"https:\/\/intrigence.com\/home\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/intrigence.com\/home\/#\/schema\/logo\/image\/","url":"https:\/\/intrigence.com\/home\/wp-content\/uploads\/2025\/05\/cropped-Untitled-design-8.png","contentUrl":"https:\/\/intrigence.com\/home\/wp-content\/uploads\/2025\/05\/cropped-Untitled-design-8.png","width":2271,"height":302,"caption":"intrigence.com"},"image":{"@id":"https:\/\/intrigence.com\/home\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/intrigence.com\/home\/#\/schema\/person\/5922828aaf1205f90f184761b59ac52d","name":"wp-user-vx6ciq","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/intrigence.com\/home\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f0add29126860514c28d228b52a705b8c831acd20a0fee2388d1f1d5c66cf8ce?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f0add29126860514c28d228b52a705b8c831acd20a0fee2388d1f1d5c66cf8ce?s=96&d=mm&r=g","caption":"wp-user-vx6ciq"},"sameAs":["https:\/\/intrigence.com"],"url":"https:\/\/intrigence.com\/home\/author\/wp-user-vx6ciq\/"}]}},"_links":{"self":[{"href":"https:\/\/intrigence.com\/home\/wp-json\/wp\/v2\/posts\/1418","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/intrigence.com\/home\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/intrigence.com\/home\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/intrigence.com\/home\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/intrigence.com\/home\/wp-json\/wp\/v2\/comments?post=1418"}],"version-history":[{"count":7,"href":"https:\/\/intrigence.com\/home\/wp-json\/wp\/v2\/posts\/1418\/revisions"}],"predecessor-version":[{"id":1842,"href":"https:\/\/intrigence.com\/home\/wp-json\/wp\/v2\/posts\/1418\/revisions\/1842"}],"wp:attachment":[{"href":"https:\/\/intrigence.com\/home\/wp-json\/wp\/v2\/media?parent=1418"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/intrigence.com\/home\/wp-json\/wp\/v2\/categories?post=1418"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/intrigence.com\/home\/wp-json\/wp\/v2\/tags?post=1418"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}